Lauren Santye, Assistant Editor

Nearly half of patients required 10 or more office visits before receiving a Crohn's disease diagnosis.

The cost associated with prescription opioid abuse continues to climb.

Lebrikizumab caused a significant reduction of asthma exacerbations in people with high levels of serum periostin or blood eosinophils.

BioMarin's AAV 5 factor VIII vector restores FVIII plasma concentrations, which are essential for creating blood clots in hemophilia A patients.

Researchers examine the risk of cancer recurrence among inflammatory bowel disease patients who take anti-TNF therapy.

Children of mothers who took atazanavir showed slightly decreased scores on language and social-emotional development.

Durvalumab and tremelimumab was active in patients with or without tumor expression of PD-L1 in NSCLC.

Monitoring tool can help fight fraud, safeguard taxpayer dollars, and protect beneficiaries.

Medication spending waste can be reduced with smaller vials of cancer drugs, study finds.

High cost infused cancer drugs are packaged containing quantities larger than needed to treat patients.

Notice includes payment parameters that seek to establish new standards to improve continuity in the Marketplace.

Improvements seek to promote continuity in the Marketplace with a goal of ensuring that health care coverage is accessible and affordable to consumers.

BLA for omalizumab (Xolair) is indicated for children aged 6 to 11 years with moderate-to-severe persistent asthma.

Odefsey can be used as a replacement for antiretroviral therapy in HIV-positive patients who are virologically-suppressed.

Odefsey is the smallest single tablet regimen to treat patients 12-years-old and above infected with HIV.

Memory-enhancing neurological drug may eventually generate precise therapies for autism and Alzheimer's disease.

NASP addresses what defines a specialty pharmacy and specialty medications.

Men diagnosed with cancer under age 25 far less likely to have children and more likely to take infertility drugs.

Charlie Sheen's announcement that he is HIV-positive may lead to a new era of HIV preventative efforts.

Verapamil shows promise for patients with type 1 diabetes or type 2 diabetes and damaged beta cells.

Viekirax and Exviera combination showed promising results in the treatment of patients with chronic HCV genotype 1b with compensated cirrhosis.

Combination of sialidase and cucurbitacin I shows substantial antitumor activity in sarcoma therapy.

The combined impact of anti-cancer treatments and exercise holds promise for shrinking tumors.

Prior studies have found that Rac1 is a molecule that maintains chronic neuropathic pain resulting from injury to the nervous system.

Everolimus (Afinitor) treats progressive, non-functional neuroendocrine tumors of gastrointestinal or lung origin.

Everolimus (Afinitor) treats progressive, non-functional neuroendocrine tumors of gastrointestinal or lung origin.

Gazyva plus bendamustine provides a new option to significantly reduce the risk of death.

FDA approval for Gazyva gives new option to patients with follicular lymphoma who did not respond to a regimen containing rituximab (Rituxan).

Researchers compare side effects for top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Researchers compare top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.